Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nathan

Showing results (91-100 of 245) with videos related to

Pageof 25
Sort By:
The American Journal of Medicine|May 30, 2002
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetesRichard W Grant, Enrico Cagliero, Patricia Murphy-Sheehy, et al.
Diabetes Care|November 7, 2012
Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP)Linda M Delahanty, Mark Peyrot, Peter J Shrader, et al.
Diabetes|October 29, 2010
Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetesMaria F Lopes-Virella, Kelly J Hunt, Nathaniel L Baker, et al.
Journal of Diabetes Science and Technology|May 31, 2014
A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and EnliteEdward R Damiano, Katherine McKeon, Firas H El-Khatib, et al.
Diabetologia|July 17, 2017
The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC studyIonut Bebu, Barbara H Braffett, Rodica Pop-Busui, et al.
Diabetes|September 11, 2014
Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC, John M Lachin, Neil H White, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetesDeborah J Wexler, David M Nathan, Richard W Grant, et al.
Diabetes|July 28, 2004
Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on AgingDeirdre R Blake, James B Meigs, Denis C Muller, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2010
Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to knowRobert J Smith, David M Nathan, Silva A Arslanian, et al.
Diabetes Care|December 28, 2002
Tests of glycemia in diabetesDavid E Goldstein, Randie R Little, Rodney A Lorenz, et al.
Pageof 25

Showing results (91-100 of 245) with videos related to

Sort By:
Pageof 25
The American Journal of Medicine|May 30, 2002
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetesRichard W Grant, Enrico Cagliero, Patricia Murphy-Sheehy, et al.
Diabetes Care|November 7, 2012
Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP)Linda M Delahanty, Mark Peyrot, Peter J Shrader, et al.
Diabetes|October 29, 2010
Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetesMaria F Lopes-Virella, Kelly J Hunt, Nathaniel L Baker, et al.
Journal of Diabetes Science and Technology|May 31, 2014
A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and EnliteEdward R Damiano, Katherine McKeon, Firas H El-Khatib, et al.
Diabetologia|July 17, 2017
The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC studyIonut Bebu, Barbara H Braffett, Rodica Pop-Busui, et al.
Diabetes|September 11, 2014
Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC, John M Lachin, Neil H White, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetesDeborah J Wexler, David M Nathan, Richard W Grant, et al.
Diabetes|July 28, 2004
Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on AgingDeirdre R Blake, James B Meigs, Denis C Muller, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2010
Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to knowRobert J Smith, David M Nathan, Silva A Arslanian, et al.
Diabetes Care|December 28, 2002
Tests of glycemia in diabetesDavid E Goldstein, Randie R Little, Rodney A Lorenz, et al.
Pageof 25